Home/Filings/4/0001209191-21-052290
4//SEC Filing

Schlesinger Michael A. 4

Accession 0001209191-21-052290

CIK 0001828443other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:41 PM ET

Size

14.8 KB

Accession

0001209191-21-052290

Insider Transaction Report

Form 4
Period: 2021-08-16
Schlesinger Michael A.
EVP, GC and Secretary
Transactions
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-08-16$6.28/sh+4,000$25,12091,637 total
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-08-18$20.14/sh41,015$826,01387,637 total
  • Exercise/Conversion

    Stock Option

    2021-08-1841,015293,507 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (41,015 underlying)
  • Sale

    Ordinary Shares, $0.00001 par value

    2021-08-16$20.03/sh4,000$80,11087,637 total
  • Exercise/Conversion

    Ordinary Shares, $0.00001 par value

    2021-08-18$6.28/sh+41,015$257,574128,652 total
  • Exercise/Conversion

    Stock Option

    2021-08-164,000334,522 total
    Exercise: $6.28Exp: 2024-10-22Ordinary Shares, $0.00001 par value (4,000 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
  • [F3]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.1500.
  • [F4]Represents the weighted average sales price for the price increments ranging from $20.0000 to $20.3200.
  • [F5]The stock option is fully vested and exercisable.

Issuer

Ortho Clinical Diagnostics Holdings plc

CIK 0001828443

Entity typeother

Related Parties

1
  • filerCIK 0001839441

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:41 PM ET
Size
14.8 KB